DOI: 10.2337/db06-0399 © 2006 by the American Diabetes Association OXPAT/PAT-1 Is a PPAR-Induced Lipid Droplet Protein That Promotes Fatty Acid Utilization
1 Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri Address correspondence and reprint requests to Perry E. Bickel, Departments of Medicine and of Cell Biology and Physiology, 660 S. Euclid Ave., Campus Box 8127, St. Louis, MO 63110. E-mail: pbickel{at}im.wustl.edu
Abbreviations:
Acadm, medium-chain acyl-CoA dehydrogenase; Acadv1, very-long-chain acyl-CoA dehydrogenase; BAT, brown adipose tissue; Cox4, cytochrome C oxidase 4; EST, expressed sequence tag; IBMX, 3-isobutyl-1-methylxanthine; LCFA, long-chain fatty acid; PAT, perilipin, adipophilin, and TIP47; PPAR, peroxisome proliferator–activated receptor; Sdha, subunit a of succinate dehydrogenase; STZ, streptozotocin; TAG, triacylglycerol; TZD, thiazolidinedione; WAT, white adipose tissue
Lipid droplet proteins of the PAT (perilipin, adipophilin, and TIP47) family regulate cellular neutral lipid stores. We have studied a new member of this family, PAT-1, and found that it is expressed in highly oxidative tissues. We refer to this protein as "OXPAT." Physiologic lipid loading of mouse liver by fasting enriches OXPAT in the lipid droplet tissue fraction. OXPAT resides on lipid droplets with the PAT protein adipophilin in primary cardiomyocytes. Ectopic expression of OXPAT promotes fatty acid–induced triacylglycerol accumulation, long-chain fatty acid oxidation, and mRNAs associated with oxidative metabolism. Consistent with these observations, OXPAT is induced in mouse adipose tissue, striated muscle, and liver by physiological (fasting), pathophysiological (insulin deficiency), pharmacological (peroxisome proliferator–activated receptor [PPAR] agonists), and genetic (muscle-specific PPAR
This article has been cited by other articles:
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||